- UK stocks were slightly lower on Monday as investors grappled with ongoing Brexit uncertainty and lingering trade tension between the US and China.

UK data on mortgage lending showed that mortgage approvals had fallen more than expected in August.

At 1200, the benchmark FTSE 100 index had fallen 18 points to 7.407.82.

Pharmaceutical giant GlaxoSmithKline added 1.1% to £17.44 after it reported positive trial results for separate treatments for ovarian cancer, and head and neck squamous cell carcinoma.

Rival pharmaceutical company AstraZeneca shed 1.5% to £72.747 despite it reporting positive trial results for separate treatments for ovarian cancer and lung cancer.

Shell fell by 1% to £23.85 after the oil giant introduced new quarterly production updates, which, for the third quarter, included a forecast of between 2.60m and 2.65m barrels of oil equivalent output per day.

Residential landlord Grainger drifted 0.2% lower to 246.8p on announcing that it would forward fund a 284-home private rented sector development in Sheffield for £42m.

Mining company Polymetal International fell 1.1% to £11.35 even as it released a new resource update at its Viksha platinum-group metals deposit in Russia that confirmed its potential as a large open-pit project.

Television content producer Zinc Media slumped 19% to 0.27p as it posted a full-year loss, after it had to outsource some post production work due to stretched in-house resources.

Latin American oil and gas play Echo Energy gained 3.33% to 3.1p despite reporting a widened loss for the first half of 2019, owing to lower realised oil price and restructuring costs.

Pesticides group Plant Health Care fell 3.4% to 6.5p as it posted a narrower first-half loss after it cut back on R&D and marketing expenses, amid a fall in sales.

Story provided by